Fresenius medical care starts 2025 with strong organic revenue and income growth

Strong organic revenue growth1 of 5% driven by care enablement and care delivery stable u.s. same market treatment development despite impact from a severe flu season fme25 savings of eur 68 million contributed to earnings operating income2 grew 11% at constant currency resulting in margin expansion reported operating income grew by 35% and reported net income3 by 113% net leverage ratio further improved to 2.8x and fy 2025 outlook confirmed bad homburg, germany , may 6, 2025 /prnewswire/ -- "the results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing the third and last year of our current strategic plan," said helen giza, chief executive officer of fresenius medical care. "revenue of both segments grew organically, and the phasing of the operating income development was in-line with our expectations.
FMS Ratings Summary
FMS Quant Ranking